Pediatric Frontal and Nasal Bispectral Index
An Accuracy of Bispectral Index Monitoring in an Alternative Nasal Position Compared With Standard Frontal Position in Pediatric Patients Under General Anesthesia With Sevoflurane
1 other identifier
interventional
40
1 country
1
Brief Summary
To compare the accuracy of frontal versus nasal BIS monitoring in pediatric patients under general anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2024
CompletedFirst Posted
Study publicly available on registry
February 13, 2024
CompletedStudy Start
First participant enrolled
May 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2024
CompletedDecember 17, 2024
December 1, 2024
7 months
January 15, 2024
December 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
bispectral index (BIS) value
BIS is a processed electroencephalogram (range from 0-100), the optimal value of BIS during general anesthesia is 40-60. We aim to define the differences between standard frontal BIS and nasal BIS using Bland-Altman analysis.
5 hours
Secondary Outcomes (2)
signal quality index (SQI)
5 hours
electromyography (EMG)
5 hours
Study Arms (1)
BIS
EXPERIMENTALThe patients will receive both standard frontal and nasal BIS monitoring during general anesthesia.
Interventions
* All patient will receive standard monitoring (EKG, Blood pressure, pulse oximetry), and BIS transducer placement at standard frontal area before anesthesia. * Sedative medication can be given as appropriate. * Anesthesia induction by inhalation induction with sevoflurane (if intravenous line not presented) or intravenous induction with thiopental 5-6 mg/kg IV * Other medication including fentanyl 1 mcg/kg IV and cisatracurium 0.1-0.2 mg/kg IV will be given and the patient will be intubated. * The second BIS will be installed on the bridge of the nose and temporal on the same side as frontal BIS. * The patient will be maintained with sevoflurane and other anesthetic drugs as appropriate, adjusted per frontal BIS (40-60). * The frontal BIS and the nasal BIS will be measured until the endotracheal tube is being removed. If the patient has moved until it was impossible to measure the BIS or has any necessity to cancel the BIS measurement. The BIS measurement can be stopped.
Eligibility Criteria
You may qualify if:
- Pediatric patients undergoing general anesthesia
- American Society of Anesthesiologists physical status 1-3
You may not qualify if:
- Patients with neurological diseases
- Patients who are using anticonvulsant drugs
- Patients who is expected to be intubated and return to the pediatric intensive care unit
- Patients undergoing head and face surgery
- Patients undergoing surgery in the prone position
- Patients who have contraindications to sevoflurane, thiopental, fentanyl, and cisatracurium
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mahidol Universitylead
- Siriraj Hospitalcollaborator
Study Sites (1)
Siriraj Hospital
Bangkok Noi, Bangkok, 10700, Thailand
Related Publications (1)
Nelson P, Nelson JA, Chen AJ, Kofke WA. An alternative position for the BIS-Vista montage in frontal approach neurosurgical cases. J Neurosurg Anesthesiol. 2013 Apr;25(2):135-42. doi: 10.1097/ANA.0b013e31826ca3a0.
PMID: 23456030BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Taniga Kiatchai, MD.
Siriraj Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2024
First Posted
February 13, 2024
Study Start
May 3, 2024
Primary Completion
November 15, 2024
Study Completion
November 15, 2024
Last Updated
December 17, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share